The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Trilok Potluri & PACs
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Promoter Trilok Potluri and PAC Vamsi Krishna Potluri converted a combined 50,00,000 warrants into equity shares on 10 September 2025 via preferential allotment, each receiving 25,00,000 shares. This represents a 5.64% increase in the promoter group's voting share capital. After the conversion, the promoter group's total holding (shares + encumbered shares) stands at 71.90% of the company's paid-up capital, which has increased to 9,36,52,030 equity shares of Re. 1 each. Direct voting shareholding of the promoter group rose from 41.35% to 46.99%.
This is a promoter-led increase in equity stake, signalling confidence in the company's prospects. However, the promoter group's combined holding is now above 70%, leaving limited free float for public shareholders, which may affect liquidity in the stock.